Felix Oden

499 total citations
11 papers, 348 citations indexed

About

Felix Oden is a scholar working on Physiology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Felix Oden has authored 11 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Pharmacology. Recurrent topics in Felix Oden's work include Alzheimer's disease research and treatments (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Felix Oden is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Felix Oden collaborates with scholars based in Germany, Switzerland and United States. Felix Oden's co-authors include André Mueller, Andrew Stephens, Ludger M. Dinkelborg, Mathias Berndt, Heiko Kroth, Francesca Capotosti, David T. Hickman, Andrea Pfeifer, Jérôme Molette and Heribert Schmitt‐Willich and has published in prestigious journals such as The Journal of Experimental Medicine, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Felix Oden

11 papers receiving 346 citations

Peers

Felix Oden
Julie Czerkowicz United States
Sheila Ulufatu United States
Alison Smigova United Kingdom
Y. Venel France
César Márquez United States
Frances Chow United States
Felix Oden
Citations per year, relative to Felix Oden Felix Oden (= 1×) peers Isabelle Paré

Countries citing papers authored by Felix Oden

Since Specialization
Citations

This map shows the geographic impact of Felix Oden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix Oden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix Oden more than expected).

Fields of papers citing papers by Felix Oden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felix Oden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix Oden. The network helps show where Felix Oden may publish in the future.

Co-authorship network of co-authors of Felix Oden

This figure shows the co-authorship network connecting the top 25 collaborators of Felix Oden. A scholar is included among the top collaborators of Felix Oden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felix Oden. Felix Oden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kroth, Heiko, Felix Oden, Jérôme Molette, et al.. (2021). Structure-activity relationship around PI-2620 highlights the importance of the nitrogen atom position in the tricyclic core. Bioorganic & Medicinal Chemistry. 52. 116528–116528. 7 indexed citations
2.
Kroth, Heiko, Felix Oden, Jérôme Molette, et al.. (2021). PI-2620 Lead Optimization Highlights the Importance of Off-Target Assays to Develop a PET Tracer for the Detection of Pathological Aggregated Tau in Alzheimer’s Disease and Other Tauopathies. Journal of Medicinal Chemistry. 64(17). 12808–12830. 13 indexed citations
3.
Gabellieri, Emanuele, Francesca Capotosti, Jérôme Molette, et al.. (2020). Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c’]dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer’s disease and other tauopathies. European Journal of Medicinal Chemistry. 204. 112615–112615. 6 indexed citations
4.
Kroth, Heiko, Felix Oden, Jérôme Molette, et al.. (2019). Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies. European Journal of Nuclear Medicine and Molecular Imaging. 46(10). 2178–2189. 134 indexed citations
5.
Hammer, Stefanie, Sabine Zitzmann-Kolbe, Felix Oden, et al.. (2019). Abstract 1141: Preclinical analysis of biodistribution and PET imaging of a zirconium-89 labeled PSMA-targeted antibody-chelator conjugate. Cancer Research. 79(13_Supplement). 1141–1141. 3 indexed citations
6.
Kieback, Elisa, Stephen F. Marino, Felix Oden, et al.. (2018). CAR T Cells with Enhanced Sensitivity to B Cell Maturation Antigen for the Targeting of B Cell Non-Hodgkin’s Lymphoma and Multiple Myeloma. Molecular Therapy. 26(8). 1906–1920. 40 indexed citations
7.
Lohrke, Jessica, Hölger Siebeneicher, Markus Berger, et al.. (2017). 18F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi. Journal of Nuclear Medicine. 58(7). 1094–1099. 36 indexed citations
8.
Mueller, André, Heiko Kroth, Hanno Schieferstein, et al.. (2017). [P2–381]: PRECLINICAL CHARACTERIZATION OF PI‐2620, A NOVEL TAU PET TRACER FOR DETECTION OF TAU IN AD AND OTHER TAUOPATHIES. Alzheimer s & Dementia. 13(7S_Part_15). 6 indexed citations
9.
Mueller, André, Heiko Kroth, Hanno Schieferstein, et al.. (2017). [IC‐P‐192]: PRECLINICAL CHARACTERIZATION OF PI‐2620, A NOVEL TAU PET TRACER FOR DETECTION OF TAU IN AD AND OTHER TAUOPATHIES. Alzheimer s & Dementia. 13(7S_Part_3). 2 indexed citations
10.
Oden, Felix, Stephen F. Marino, Jörg Westermann, et al.. (2015). Potent anti‐tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma. Molecular Oncology. 9(7). 1348–1358. 24 indexed citations
11.
Tiller, Thomas, J. Köfer, Cornelia Kreschel, et al.. (2010). Development of self-reactive germinal center B cells and plasma cells in autoimmune FcγRIIB-deficient mice. The Journal of Experimental Medicine. 207(12). 2767–2778. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026